SCHEMBL26158

SCHEMBL26158

NCCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1800088 0.95
Bromide SCHEMBL2023772 0.95
SCHEMBL1416962 0.86
Water SCHEMBL4437253 0.82
SCHEMBL2501714 0.82 DNM1 (0.67)
SCHEMBL23697928 0.82 DNM1 (0.67)
SCHEMBL2501735 0.82 DNM1 (0.67)
SCHEMBL1417018 0.82
Hydrochloric Acid SCHEMBL5205804 0.82
SCHEMBL7639784 0.82 DNM1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 468 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117843902-A Preparation method of graphene modified polyaspartic acid ester resin and paint 深圳飞扬骏研新材料股份有限公司 2024-04-09 CN claimed
US-20230337447-A1 QUANTUM DOT LIGHT EMITTING DEVICE AND MANUFACTURING METHOD THEREFOR, AND DISPLAY DEVICE Beijing Boe Technology Development Co., Ltd. (CN) 2023-10-19 US claimed
US-RE49481-E1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease HOFFMANN-LA ROCHE INC. (US) 2023-04-04 US claimed
CN-115394930-A Light-emitting device, preparation method thereof and display device 北京京东方技术开发有限公司 2022-11-25 CN claimed
WO-2022062718-A1 QUANTUM DOT LIGHT EMITTING DEVICE AND MANUFACTURING METHOD THEREFOR, AND DISPLAY DEVICE 京东方科技集团股份有限公司 2022-03-31 WO claimed
US-10421722-B2 Sulfur-containing compounds targeting vesicular acetylcholine transporter WASHINGTON UNIVERSITY (US) 2019-09-24 US claimed
US-20170355675-A1 SULFUR-CONTAINING COMPOUNDS TARGETING VESICULAR ACETYLCHOLINE TRANSPORTER WASHINGTON UNIVERSITY (US) 2017-12-14 US claimed
CN-106061967-A Heteroaryl substituted nicotinamide compounds 百时美施贵宝公司 2016-10-26 CN claimed
EP-2742039-B1 COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE HOFFMANN LA ROCHE (CH) 2015-09-16 EP claimed
US-8871756-B2 Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease HOFFMANN-LA ROCHE INC. (US) 2014-10-28 US claimed
US-20100261727-A1 2-ARYLBENZOTHIOPHENE DERIVATIVES OR PHARCEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARCEUTICAL COMPOSITION FOR THE DIAGNOSIS OR TREATMENT OF DEGENERATIVE BRAIN DISEASE CONTAINING THE SAME AS ACTIVE INGREDIENT Industry-University Cooperation Foundation Sogang University 2010-10-14 US claimed
CN-101857587-A 2-aryl benzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and phrmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient SGU HOLDINGS CO LTD 2010-10-13 CN claimed
WO-2008034895-A2 ANSAMYCIN DERIVATIVES DISCOVERY PARTNERS INTERNATIONAL GMBH (DE) 2008-03-27 WO claimed
US-20040097522-A1 Triazolopyrimidines BAYER CROPSCIENCE AG (DE) 2004-05-20 US claimed
EP-1349859-A2 TRIAZOLOPYRIMIDINES Bayer CropScience AG (DE) 2003-10-08 EP claimed
US-6596868-B2 Reacting a cycloheptatriene derivative with a primary amine or ammonia in the presence of a base NIHON MEDI-PHYSICS CO., LTD. (JP) 2003-07-22 US claimed
US-20030109708-A1 Process for synthesizing anhydroecgonine derivative NIHON MEDI-PHYSICS CO., LTD. 2003-06-12 US claimed
WO-2002050077-A2 TRIAZOLOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2002-06-27 WO claimed
US-20010020096-A1 Process for synthesizing anhydroecgonine derivative NIHON MEDI-PHYSICS CO., LTD. (JP) 2001-09-06 US claimed
EP-1127887-A1 Process for synthesizing anhydroecgonine derivative NIHON MEDI-PHYSICS Co., Ltd. (JP) 2001-08-29 EP claimed